DG
AGN

Davidson & Garrard’s Allergan plc AGN Stock Holding History

Davidson & Garrard’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-836
Closed -$224K – 186
2016
Q1 		$224K Hold
836
– – 0.06% 161
2015
Q4 		$261K Hold
836
– – 0.06% 161
2015
Q3 		$227K Hold
836
– – 0.06% 166
2015
Q2 		$254K Hold
836
– – 0.06% 169
2015
Q1 		$249K Buy
836
+36
+5% +$10.3K 0.06% 166
2014
Q4 		$206K Buy
+800
New +$200K 0.05% 173

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Davidson & Garrard's AGN Position: Q2 2016 in Review

Davidson & Garrard sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 836 shares — an estimated $224K sold.

Davidson & Garrard first reported a position in AGN in Q4 2014 and held it in 6 quarters. The position peaked at $261K in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Davidson & Garrard reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Davidson & Garrard sold 836 Allergan plc shares in Q2 2016, an estimated $224K.
  • Davidson & Garrard first reported a position in Allergan plc in Q4 2014 and held it in 6 quarters.
  • Davidson & Garrard's Allergan plc position peaked at $261K in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Davidson & Garrard's 13F filing for Q2 2016, filed 4 Aug 2016.